Favorable Changes in Cardiac Geometry and Function Following Gastric Bypass Surgery 2-Year Follow-Up in the Utah Obesity Study

Division of Cardiology, University of Utah School of Medicine, Salt Lake City, USA.
Journal of the American College of Cardiology (Impact Factor: 15.34). 02/2011; 57(6):732-9. DOI: 10.1016/j.jacc.2010.10.017
Source: PubMed

ABSTRACT The objective of this study was to test the hypothesis that gastric bypass surgery (GBS) would favorably impact cardiac remodeling and function.
GBS is increasingly used to treat severe obesity, but there are limited outcome data.
We prospectively studied 423 severely obese patients undergoing GBS and a reference group of severely obese subjects that did not have surgery (n = 733).
At a 2-year follow up, GBS subjects had a large reduction in body mass index compared with the reference group (-15.4 ± 7.2 kg/m(2) vs. -0.03 ± 4.0 kg/m(2); p < 0.0001), as well as significant reductions in waist circumference, systolic blood pressure, heart rate, triglycerides, low-density lipoprotein cholesterol, and insulin resistance. High-density lipoprotein cholesterol increased. The GBS group had reductions in left ventricular (LV) mass index and right ventricular (RV) cavity area. Left atrial volume did not change in GBS but increased in reference subjects. In conjunction with reduced chamber sizes, GBS subjects also had increased LV midwall fractional shortening and RV fractional area change. In multivariable analysis, age, change in body mass index, severity of nocturnal hypoxemia, E/E', and sex were independently associated with LV mass index, whereas surgical status, change in waist circumference, and change in insulin resistance were not.
Marked weight loss in patients undergoing GBS was associated with reverse cardiac remodeling and improved LV and RV function. These data support the use of bariatric surgery to prevent cardiovascular complications in severe obesity.


Available from: Robert Farney, Jun 07, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective Weight loss improves cardiac abnormalities associated with severe obesity. We evaluated the impact of weight loss following laparoscopic gastric bypass (LGBP) on left ventricular (LV) geometry and function in obese patients. Methods Twenty-six patients with severe obesity (41 ± 8 years, 50% women) underwent Doppler echocardiograms before and after LGBP, to measure LV geometry, excess of LV mass relative to hemodynamic load and systolic and diastolic function. Results Pre-operatively, 85% of patients exhibited LVH, and 62% hypertension and metabolic syndrome, reflecting high cardiometabolic risk. After 8 ± 4 months of follow-up, the average weight loss was 19 ± 8%. Weight loss was significantly associated with improved metabolic parameters and reduced heart rate (−9 bpm), systolic (−11 mmHg) and diastolic (−6 mmHg) blood pressure (all p < 0.02). After surgery, there was significant reduction in relative wall thickness (0.43 ± 0.07 versus 0.39 ± 0.06), LV mass index (63 ± 14 g/m2.7 versus 49 ± 10 g/m2.7) and excess of LV mass in relation to hemodynamic load (all p < 0.004). LVH remained in 54% of patients, hypertension in 23% and metabolic syndrome in 27%. Ejection fraction and Doppler indices of diastolic function did not change significantly, even after adjusting for changes in heart rate. All favorable changes in LV geometry and function were also confirmed in the subgroup with <9 month follow-up (median), whereas no further improvement could be detected in patients with longer follow-up. Conclusions In patient with severe obesity, LV geometry and systolic function improved rapidly after LGBP, without evidence of further improvement during prolonged follow-up.
    Obesity Research & Clinical Practice 07/2012; 6(3):e189–e196. DOI:10.1016/j.orcp.2012.02.008 · 0.70 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The detection of left ventricular hypertrophy (LVH) is recommended for risk prediction, and changes in LV geometry may provide further prognostic information. Obesity is a major determinant of LVH, but the approach to LVH detection in obese hypertensives remains a challenge. In the present review, we discuss evidence leading to the recent acceptance of the use of LV mass indexed to height(2.7) or height(1.7) rather than body surface area, for LVH detection and its regression in obesity. We also review recent findings which indicate that obesity-induced LVH may be associated with concentric LV remodeling, and hence, that the presence of concentric LVH in obesity should not be assumed to indicate a cause of LVH other than obesity. We also discuss recent evidence for obesity and blood pressure producing additive and interactive effects on LV mass, and hence, that weight loss and blood pressure reduction are required to achieve appropriate regression.
    Current Hypertension Reports 04/2015; 17(4):539. DOI:10.1007/s11906-015-0539-z · 3.90 Impact Factor
  • Circulation Cardiovascular Imaging 05/2012; 5(3):286-8. DOI:10.1161/CIRCIMAGING.112.974840 · 6.75 Impact Factor